285 - Mental Health Management in Youth: A Review of the Long-Term Risks and Benefits of Psychotropic Medications

Publication Number: 3274.285

Sashmitaa Bagavathiraj, University of Minnesota Medical School, Eden Prairie, MN, United States; Elena Geiger-simpson, University of Minnesota School of Nursing, Minneapolis, MN, United States

Background: The increasing rates of mental health issues among youth represent a critical public health concern, with conditions such as depression, anxiety, behavioral disorders becoming more prevalent in recent decades. Psychotropic medications are often prescribed as a first-line or adjunctive treatment, as they can provide stabilization of acute symptoms. However, prolonged use of these medications carries potential lifelong risks. While they can manage acute symptoms, extended exposure during the critical stages of brain development can have negative effects on mental and physical health.

Objective: The purpose of this literature review is to explore the positive and negative outcomes of long-term psychotropic use in children and adolescents, with focus on brain maturation, cognitive functioning, and physical health outcomes.

Design/Methods: A systematic search was conducted in PubMed, PscyhINFO, Cochrane Library, and CINAHL databases using the keywords psychiatric disorders, psychotropic medications, children and adolescents, long-term effects, and adverse outcomes. Inclusion criteria for this review were studies published within the last 25 years (1999-2024) that investigated youth between the ages of 6-18 years.

Results: Eighteen studies met inclusion criteria, consisting randomized controlled trials, systematic reviews, meta-analyses, and cohort studies. Findings indicate that psychotropic medications often provide short-term relief, improving mood stability, attention, and quality of life. However, evidence also demonstrates significant risks associated with chronic use, including increased susceptibility to cardiometabolic diseases, weight gain, endocrine disruption, and drug-induced movement disorders such as tardive dyskinesia. There remains limited understanding of the long-term influence of these medications on neuropsychiatric symptoms and higher-order cognitive functions.

Conclusion(s): The findings highlight the need for cautious prescribing practices and the development of clinical guidelines that minimize long-term harm while ensuring appropriate treatment of psychiatric conditions in youth. Preventative strategies and community-based health promotion efforts should be prioritized to reduce reliance on pharmacological interventions as the sole treatment. Future research should focus on longitudinal outcomes to clarify the developmental, cognitive, and psychosocial effects of prolonged psychotropic use, thereby informing more well-balanced approaches to adolescent mental health care.

Common Adverse Effects of Psychotropic Medications in Adolescents
This table summarizes the most frequently reported adverse effects of psychotropic medications, their associated drug classes, and their potential impact on adolescent health. While these medications can be effective for managing symptoms, side effects such as sleep problems, appetite changes, gastrointestinal issues, and motor impairments raise concerns about long-term safety.

Psychotropic Medication Prescriptions in U.S. Adolescents (1999-2022)
This graph shows the steady increase in psychotropic medication prescriptions per 1,000 adolescents in the U.S. over the past two decades, with rates rising from 5.2% in 1999 to 16.1% in 2022.

Literature Review Search and Selection Process
The flowchart outlines the methodology for this review, including databases searched, keywords used, and inclusion criteria. From studies published between 1999 and 2024, a total of 18 eligible studies were reviewed to assess the long-term effects of psychotropic medication use in children and adolescents.